A Clinical Study of Nimotuzumab in Combination With Concurrent Chemotherapy and Radiation for Patients With Local Advanced Esophageal Squamous Cell Carcinoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin; Fluorouracil
- Indications Oesophageal cancer
- Focus Therapeutic Use
- Sponsors Biotech Pharmaceutical
- 19 Aug 2015 Planned End Date changed from 1 Feb 2014 to 1 Jan 2016 as per ClinicalTrials.gov record.
- 19 Aug 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 13 Nov 2010 New trial record